Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| GT Biopharma, Inc.GTBP · Entity 7878 | Chief Financial Officer | September 04, 2025 | September 08, 2025 |
| Prairie Operating Co.CRKR · Entity 7132 | Chief Financial Officer | December 23, 2021 | January 21, 2022 |
| Research Solutions, Inc.RSSS · Entity 6984 | CFO & Secretary | September 20, 2021 | September 21, 2021 |
| SRAX, Inc.SRAX · Entity 95766 | Chief Financial Officer | March 14, 2023 | March 22, 2023 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
GT Biopharma, Inc.
Report date September 04, 2025 · Filed September 08, 2025
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Option to purchase Common StockSEC Table II · derivative / convertible security · Conversion / exercise price $1.33 · Expires 2035-08-19 | Direct | 50,000 |
Reported balance
After 2025-09-04 transaction · row 1
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 1 · 2025-09-04 · Grant · Acquired 50,000 · Balance 50,000 F1: The option vests in four equal quarterly installments beginning on January 1, 2025. |
| Option to purchase Common StockSEC Table II · derivative / convertible security · Conversion / exercise price $1.33 · Expires 2035-08-19 | Direct | 50,000 |
Reported balance
After 2025-09-04 transaction · row 2
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 2 · 2025-09-04 · Grant · Acquired 50,000 · Balance 50,000 F2: The option vests in four equal quarterly installments beginning on January 1, 2026. |
Filing footnotes · ownership attribution and instrument terms
F1: The option vests in four equal quarterly installments beginning on January 1, 2025.
F2: The option vests in four equal quarterly installments beginning on January 1, 2026.
Prairie Operating Co.
Report date December 23, 2021 · Filed January 21, 2022
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| common sharesSEC Table I · non-derivative | Direct | 30,000 |
Reported balance
Holding disclosure · report date 2021-12-23 · row 1
Holding and transaction disclosures are not merged.
1 source rowRow 1 · Balance 30,000 |
| OptionsSEC Table II · derivative / convertible security · Conversion / exercise price $2.65 | Direct | Not disclosed |
Reported balance
Holding disclosure · report date 2021-12-23 · row 2
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 2 · Balance Not disclosed F1: Options granted pursuant to incentive and award plans. 25% of the options vest when the common share VWAP computed over 30 consecutive trading days reaches $2.50, $3.00, $3.50 and $4.00. |
Filing footnotes · ownership attribution and instrument terms
F1: Options granted pursuant to incentive and award plans. 25% of the options vest when the common share VWAP computed over 30 consecutive trading days reaches $2.50, $3.00, $3.50 and $4.00.
Research Solutions, Inc.
Report date September 20, 2021 · Filed September 21, 2021
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 340,602 |
Reported balance
After 2021-09-20 transaction · row 1
1 source rowRow 1 · 2021-09-20 · Tax withholding · Disposed 5,710 · Balance 340,602 F1: The reporting person sold these shares to the registrant to cover taxes on vested restricted stock, as approved by the Compensation Committee of the Registrant's Board of Directors. |
| Common StockSEC Table I · non-derivative | IndirectBy Spouse | 5,000 |
Reported balance
Holding disclosure · report date 2021-09-20 · row 2
Holding and transaction disclosures are not merged.
1 source rowRow 2 · Balance 5,000 |
| Common StockSEC Table I · non-derivative | IndirectAs Custodian for D. Urban UTMA CA | 5,000 |
Reported balance
Holding disclosure · report date 2021-09-20 · row 3
Holding and transaction disclosures are not merged.
1 source rowRow 3 · Balance 5,000 |
| Common StockSEC Table I · non-derivative | IndirectAs Custodian for G. Urban UTMA CA | 5,000 |
Reported balance
Holding disclosure · report date 2021-09-20 · row 4
Holding and transaction disclosures are not merged.
1 source rowRow 4 · Balance 5,000 |
| Common StockSEC Table I · non-derivative | IndirectAs Custodian for L. Urban UTMA CA | 5,000 |
Reported balance
Holding disclosure · report date 2021-09-20 · row 5
Holding and transaction disclosures are not merged.
1 source rowRow 5 · Balance 5,000 |
Filing footnotes · ownership attribution and instrument terms
F1: The reporting person sold these shares to the registrant to cover taxes on vested restricted stock, as approved by the Compensation Committee of the Registrant's Board of Directors.
SRAX, Inc.
Report date March 14, 2023 · Filed March 22, 2023
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Class A Common Stock Purchase OptionSEC Table II · derivative / convertible security · Conversion / exercise price $0.44 | Direct | 300,000 |
Reported balance
After 2023-03-14 transaction · row 1
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 1 · 2023-03-14 · Grant · Acquired 300,000 · Balance 300,000 F1: Represents options to purchase Class A Common Stock issued to reporting person as consideration in connection with the reporting person's appointment as the Issuer's Chief Financial Officer (the "Option Grant"). F2: The Option Grant vests as follows: (i) 40% to vest upon completion, during the term in which the reporting person is employed by the Issuer as Chief Financial Officer, of the Issuer's delinquent reports with the U.S. Securities and Exchange Commission for the quarters ended June 30, 2022 and September 30, 2022, and for the year ended December 31, 2022 (collectively, the "Delinquent Reports"), and (ii) the remaining 60% to vest in equal quarterly installments over the following two year period, subject to the completion of the Delinquent Reports. The Option Grant will fully vest in connection with a Change in Control. |
Filing footnotes · ownership attribution and instrument terms
F1: Represents options to purchase Class A Common Stock issued to reporting person as consideration in connection with the reporting person's appointment as the Issuer's Chief Financial Officer (the "Option Grant").
F2: The Option Grant vests as follows: (i) 40% to vest upon completion, during the term in which the reporting person is employed by the Issuer as Chief Financial Officer, of the Issuer's delinquent reports with the U.S. Securities and Exchange Commission for the quarters ended June 30, 2022 and September 30, 2022, and for the year ended December 31, 2022 (collectively, the "Delinquent Reports"), and (ii) the remaining 60% to vest in equal quarterly installments over the following two year period, subject to the completion of the Delinquent Reports. The Option Grant will fully vest in connection with a Change in Control.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| September 04, 2025 Filed Sep 8, 2025 21:45 UTC | GT Biopharma, Inc. GTBP · Entity 7878 | GrantOption to purchase Common Stock · Derivative | 50,000 | $0.00 Strike: $1.33 | $0.00 |
DisclosureSEC source: 0001641172-25-026894 · ownership.xml · derivative · entry 2 URBAN ALAN LOUIS · CIK 0001534376 · Chief Financial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 50,000 Underlying: Common Stock · 50,000 shares Expires 2035-08-19 F2 · derivative.exercise_date: The option vests in four equal quarterly installments beginning on January 1, 2026. Read SEC document |
| September 04, 2025 Filed Sep 8, 2025 21:45 UTC | GT Biopharma, Inc. GTBP · Entity 7878 | GrantOption to purchase Common Stock · Derivative | 50,000 | $0.00 Strike: $1.33 | $0.00 |
DisclosureSEC source: 0001641172-25-026894 · ownership.xml · derivative · entry 1 URBAN ALAN LOUIS · CIK 0001534376 · Chief Financial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 50,000 Underlying: Common Stock · 50,000 shares Expires 2035-08-19 F1 · derivative.exercise_date: The option vests in four equal quarterly installments beginning on January 1, 2025. Read SEC document |
| October 17, 2024 Filed Oct 22, 2024 01:13 UTC | GT Biopharma, Inc. GTBP · Entity 7878 | GrantOption to purchase Common Stock · Derivative | 23,335 | $0.00 Strike: $2.11 | $0.00 |
DisclosureSEC source: 0001493152-24-041855 · ownership.xml · derivative · entry 1 URBAN ALAN LOUIS · CIK 0001534376 · Chief Financial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 23,335 Underlying: Common Stock · 23,335 shares Expires 2034-10-16 F1 · derivative.exercise_date: 1/36th of the shares vest on the monthly anniversary of June 3, 2024 until fully vested, subject to full acceleration in the event the reporting person is involuntarily terminated by the registrant without Cause (as defined in the reporting person's Employment Agreement dated June 7, 2024), resignation by the reporting person for Good Reason (as defined in the reporting person's Employment Agreement dated June 7, 2024), or in the event of a Change in Control (as defined in the registrant's 2022 Omnibus Incentive Plan). Read SEC document |
| March 14, 2023 Filed Mar 22, 2023 14:57 UTC | SRAX, Inc. SRAX · Entity 95766 | GrantClass A Common Stock Purchase Option · Derivative | 300,000 | $0.00 Strike: $0.44 | $0.00 |
DisclosureSEC source: 0001493152-23-008508 · ownership.xml · derivative · entry 1 URBAN ALAN LOUIS · CIK 0001534376 · Chief Financial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 300,000 Underlying: Class A Common Stock · 300,000 shares Expires not disclosed F1 · security: Represents options to purchase Class A Common Stock issued to reporting person as consideration in connection with the reporting person's appointment as the Issuer's Chief Financial Officer (the "Option Grant"). F2 · derivative.exercise_date: The Option Grant vests as follows: (i) 40% to vest upon completion, during the term in which the reporting person is employed by the Issuer as Chief Financial Officer, of the Issuer's delinquent reports with the U.S. Securities and Exchange Commission for the quarters ended June 30, 2022 and September 30, 2022, and for the year ended December 31, 2022 (collectively, the "Delinquent Reports"), and (ii) the remaining 60% to vest in equal quarterly installments over the following two year period, subject to the completion of the Delinquent Reports. The Option Grant will fully vest in connection with a Change in Control. F2 · derivative.expiration_date: The Option Grant vests as follows: (i) 40% to vest upon completion, during the term in which the reporting person is employed by the Issuer as Chief Financial Officer, of the Issuer's delinquent reports with the U.S. Securities and Exchange Commission for the quarters ended June 30, 2022 and September 30, 2022, and for the year ended December 31, 2022 (collectively, the "Delinquent Reports"), and (ii) the remaining 60% to vest in equal quarterly installments over the following two year period, subject to the completion of the Delinquent Reports. The Option Grant will fully vest in connection with a Change in Control. Read SEC document |
| July 15, 2022 Filed Jul 20, 2022 01:46 UTC | GT Biopharma, Inc. GTBP · Entity 7878 | GrantOption to purchase Common Stock · Derivative | 50,000 | $0.00 Strike: $2.48 | $0.00 |
DisclosureSEC source: 0001493152-22-019874 · ownership.xml · derivative · entry 1 URBAN ALAN LOUIS · CIK 0001534376 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 50,000 Underlying: Common Stock · 50,000 shares Expires 2032-07-14 F1 · derivative.exercise_date: 1/4th of the shares vest on the date of grant and on each of September 9, 2022, December 9, 2022 and March 9, 2023. Read SEC document |
| September 20, 2021 Filed Sep 21, 2021 22:26 UTC | Research Solutions, Inc. RSSS · Entity 6984 | Tax withholdingCommon Stock | 5,710 | $2.55 | $14,560.50 |
DisclosureSEC source: 0001104659-21-117985 · tm2128166-1_4seq1.xml · nonDerivative · entry 1 URBAN ALAN LOUIS · CIK 0001534376 · CFO & Secretary 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 340,602 F1 · kind: The reporting person sold these shares to the registrant to cover taxes on vested restricted stock, as approved by the Compensation Committee of the Registrant's Board of Directors. Read SEC document |
| August 05, 2021 Filed Aug 11, 2021 21:28 UTC | Research Solutions, Inc. RSSS · Entity 6984 | GrantCommon Stock | 22,303 | $0.00 | $0.00 |
DisclosureSEC source: 0001104659-21-103595 · tm2124873-1_4seq1.xml · nonDerivative · entry 1 URBAN ALAN LOUIS · CIK 0001534376 · See Remarks 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 346,312 F1 · shares: Represents a grant of shares of restricted stock ("RSAs"). 1/3rd of the RSAs vest on August 5, 2022 and 1/12th of the RSAs vest on the last day of each quarter beginning September 30, 2022 until fully vested. Read SEC document |
| June 20, 2021 Filed Jun 22, 2021 01:42 UTC | Research Solutions, Inc. RSSS · Entity 6984 | Tax withholdingCommon Stock | 2,500 | $2.50 | $6,250.00 |
DisclosureSEC source: 0001104659-21-083690 · tm2120318d2_4.xml · nonDerivative · entry 2 URBAN ALAN LOUIS · CIK 0001534376 · CFO & Secretary 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 324,009 F1 · kind: The reporting person sold these shares to the registrant to cover taxes on vested restricted stock, as approved by the Compensation Committee of the Registrant's Board of Directors. Read SEC document |
| June 18, 2021 Filed Jun 22, 2021 01:42 UTC | Research Solutions, Inc. RSSS · Entity 6984 | SaleCommon Stock | 5,000 | $2.43 | $12,150.00 |
DisclosureSEC source: 0001104659-21-083690 · tm2120318d2_4.xml · nonDerivative · entry 1 URBAN ALAN LOUIS · CIK 0001534376 · CFO & Secretary 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 326,509 Read SEC document |
| June 14, 2021 Filed Jun 17, 2021 00:13 UTC | Research Solutions, Inc. RSSS · Entity 6984 | SaleCommon Stock | 5,000 | $2.45 | $12,250.00 |
DisclosureSEC source: 0001104659-21-082158 · tm2120008-1_4seq1.xml · nonDerivative · entry 1 URBAN ALAN LOUIS · CIK 0001534376 · CFO & Secretary 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 331,509 Read SEC document |
| June 09, 2021 Filed Jun 10, 2021 23:38 UTC | Research Solutions, Inc. RSSS · Entity 6984 | SaleCommon Stock | 10,000 | $2.40 | $24,000.00 |
DisclosureSEC source: 0001104659-21-079629 · tm2119436-1_4seq1.xml · nonDerivative · entry 2 URBAN ALAN LOUIS · CIK 0001534376 · CFO & Secretary 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 336,509 Read SEC document |
| June 07, 2021 Filed Jun 10, 2021 23:38 UTC | Research Solutions, Inc. RSSS · Entity 6984 | Exercise / conversionCommon Stock Warrants (right to buy) · Derivative | 1,800 | $1.00 Strike: $1.25 | $1,800.00 |
DisclosureSEC source: 0001104659-21-079629 · tm2119436-1_4seq1.xml · derivative · entry 7 URBAN ALAN LOUIS · CIK 0001534376 · CFO & Secretary 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 1,800 shares Expires 2021-06-23 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: The reported securities were included within units purchased by the reporting person for $1.00 per unit. Each unit consisted of one share of common stock and one warrant to purchase three-tenths of one share of common stock. Read SEC document |
| June 07, 2021 Filed Jun 10, 2021 23:38 UTC | Research Solutions, Inc. RSSS · Entity 6984 | Exercise / conversionCommon Stock | 1,800 | $1.25 | $2,250.00 |
DisclosureSEC source: 0001104659-21-079629 · tm2119436-1_4seq1.xml · nonDerivative · entry 1 URBAN ALAN LOUIS · CIK 0001534376 · CFO & Secretary 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 346,509 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| May 11, 2021 Filed May 13, 2021 01:43 UTC | Research Solutions, Inc. RSSS · Entity 6984 | GrantCommon Stock | 7,419 | $0.00 | $0.00 |
DisclosureSEC source: 0001104659-21-065371 · tm216093d3_4.xml · nonDerivative · entry 1 URBAN ALAN LOUIS · CIK 0001534376 · CFO & Secretary 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 344,709 F1 · shares: Represents a grant of shares of restricted stock ("RSAs"). 1/3rd of the RSAs vest on May 11, 2022 and 1/12th of the RSAs vest on the last day of each quarter beginning June 30, 2022 until fully vested. Read SEC document |
| March 20, 2021 Filed Mar 22, 2021 20:48 UTC | Research Solutions, Inc. RSSS · Entity 6984 | Tax withholdingCommon Stock | 3,250 | $2.15 | $6,987.50 |
DisclosureSEC source: 0001104659-21-039757 · tm2110519d2_4.xml · nonDerivative · entry 1 URBAN ALAN LOUIS · CIK 0001534376 · CFO & Secretary 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 337,290 F1 · kind: The reporting person sold these shares to the registrant to cover taxes on vested restricted stock, as approved by the Compensation Committee of the Registrant's Board of Directors. Read SEC document |
| February 09, 2021 Filed Feb 12, 2021 20:59 UTC | Research Solutions, Inc. RSSS · Entity 6984 | GrantCommon Stock | 4,618 | $0.00 | $0.00 |
DisclosureSEC source: 0001104659-21-021864 · tm216589d4_4.xml · nonDerivative · entry 1 URBAN ALAN LOUIS · CIK 0001534376 · CFO & Secretary 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 340,540 F1 · shares: Represents a grant of shares of restricted stock ("RSAs"). 1/3rd of the RSAs vest on February 9, 2022 and 1/12th of the RSAs vest on the last day of each quarter beginning March 31, 2022 until fully vested. Read SEC document |
| December 20, 2020 Filed Dec 22, 2020 21:13 UTC | Research Solutions, Inc. RSSS · Entity 6984 | Tax withholdingCommon Stock | 24,167 | $2.21 | $53,409.07 |
DisclosureSEC source: 0001104659-20-138575 · tm2039205d1_4.xml · nonDerivative · entry 1 URBAN ALAN LOUIS · CIK 0001534376 · CFO & Secretary 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 335,922 F1 · kind: The reporting person sold these shares to the registrant to cover taxes on vested restricted stock, as approved by the Compensation Committee of the Registrant's Board of Directors. Read SEC document |
| November 17, 2020 Filed Nov 19, 2020 01:53 UTC | Research Solutions, Inc. RSSS · Entity 6984 | GrantCommon Stock | 5,399 | $0.00 | $0.00 |
DisclosureSEC source: 0001104659-20-127006 · tm2036363d5_4.xml · nonDerivative · entry 1 URBAN ALAN LOUIS · CIK 0001534376 · CFO & Secretary 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 360,089 F1 · shares: Represents a grant of shares of restricted stock ("RSAs"). 1/3rd of the RSAs vest on November 17, 2021 and 1/12th of the RSAs vest on the last day of each quarter beginning December 31, 2021 until fully vested. Read SEC document |
| September 20, 2020 Filed Sep 22, 2020 23:57 UTC | Research Solutions, Inc. RSSS · Entity 6984 | Tax withholdingCommon Stock | 12,500 | $2.29 | $28,625.00 |
DisclosureSEC source: 0001104659-20-107465 · tm2031557d1_4.xml · nonDerivative · entry 1 URBAN ALAN LOUIS · CIK 0001534376 · CFO & Secretary 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 354,690 F1 · kind: The reporting person sold these shares to the registrant to cover taxes on vested restricted stock, as approved by the Compensation Committee of the Registrant's Board of Directors. Read SEC document |
| August 03, 2020 Filed Aug 3, 2020 23:54 UTC | Research Solutions, Inc. RSSS · Entity 6984 | GrantCommon Stock | 27,600 | $0.00 | $0.00 |
DisclosureSEC source: 0001104659-20-089771 · tm2026456d1_4.xml · nonDerivative · entry 1 URBAN ALAN LOUIS · CIK 0001534376 · CFO & Secretary 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 367,190 F1 · shares: Represents a grant of shares of restricted stock ("RSAs"). 1/3rd of the RSAs vest on August 3, 2021 and 1/12th of the RSAs vest on the last day of each quarter beginning September 30, 2021 until fully vested. Read SEC document |
| June 19, 2020 Filed Jun 23, 2020 22:18 UTC | Research Solutions, Inc. RSSS · Entity 6984 | Tax withholdingCommon Stock | 10,000 | $2.68 | $26,800.00 |
DisclosureSEC source: 0001104659-20-076148 · tm2023242d2_4.xml · nonDerivative · entry 1 URBAN ALAN LOUIS · CIK 0001534376 · CFO & Secretary 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 339,590 F1 · kind: The reporting person sold these shares to the registrant to cover taxes on vested restricted stock, as approved by the Compensation Committee of the Registrant's Board of Directors. Read SEC document |
| June 12, 2020 Filed Jun 12, 2020 21:02 UTC | Research Solutions, Inc. RSSS · Entity 6984 | SaleCommon Stock | 2,172 | $3.00 | $6,516.00 |
DisclosureSEC source: 0001104659-20-072976 · tm2022561d1_4.xml · nonDerivative · entry 3 URBAN ALAN LOUIS · CIK 0001534376 · CFO & Secretary 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 349,590 Read SEC document |
| June 11, 2020 Filed Jun 12, 2020 21:02 UTC | Research Solutions, Inc. RSSS · Entity 6984 | SaleCommon Stock | 2,024 | $3.00 | $6,072.00 |
DisclosureSEC source: 0001104659-20-072976 · tm2022561d1_4.xml · nonDerivative · entry 2 URBAN ALAN LOUIS · CIK 0001534376 · CFO & Secretary 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 351,762 Read SEC document |
| June 10, 2020 Filed Jun 12, 2020 21:02 UTC | Research Solutions, Inc. RSSS · Entity 6984 | SaleCommon Stock | 404 | $3.00 | $1,212.00 |
DisclosureSEC source: 0001104659-20-072976 · tm2022561d1_4.xml · nonDerivative · entry 1 URBAN ALAN LOUIS · CIK 0001534376 · CFO & Secretary 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 353,786 Read SEC document |
| June 09, 2020 Filed Jun 9, 2020 21:50 UTC | Research Solutions, Inc. RSSS · Entity 6984 | SaleCommon Stock | 400 | $3.00 | $1,200.00 |
DisclosureSEC source: 0001104659-20-071529 · tm2022228d1_4.xml · nonDerivative · entry 5 URBAN ALAN LOUIS · CIK 0001534376 · CFO & Secretary 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 354,190 Read SEC document |
| June 08, 2020 Filed Jun 9, 2020 21:50 UTC | Research Solutions, Inc. RSSS · Entity 6984 | SaleCommon Stock | 4,300 | $2.95 | $12,685.00 |
DisclosureSEC source: 0001104659-20-071529 · tm2022228d1_4.xml · nonDerivative · entry 4 URBAN ALAN LOUIS · CIK 0001534376 · CFO & Secretary 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 354,590 Read SEC document |
| June 05, 2020 Filed Jun 9, 2020 21:50 UTC | Research Solutions, Inc. RSSS · Entity 6984 | SaleCommon Stock | 700 | $2.95 | $2,065.00 |
DisclosureSEC source: 0001104659-20-071529 · tm2022228d1_4.xml · nonDerivative · entry 3 URBAN ALAN LOUIS · CIK 0001534376 · CFO & Secretary 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 358,890 Read SEC document |
| June 05, 2020 Filed Jun 9, 2020 21:50 UTC | Research Solutions, Inc. RSSS · Entity 6984 | SaleCommon Stock | 4,990 | $2.90 | $14,471.00 |
DisclosureSEC source: 0001104659-20-071529 · tm2022228d1_4.xml · nonDerivative · entry 2 URBAN ALAN LOUIS · CIK 0001534376 · CFO & Secretary 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 359,590 Read SEC document |
| June 04, 2020 Filed Jun 9, 2020 21:50 UTC | Research Solutions, Inc. RSSS · Entity 6984 | SaleCommon Stock | 10 | $3.00 | $30.00 |
DisclosureSEC source: 0001104659-20-071529 · tm2022228d1_4.xml · nonDerivative · entry 1 URBAN ALAN LOUIS · CIK 0001534376 · CFO & Secretary 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 364,580 Read SEC document |
| May 12, 2020 Filed May 13, 2020 22:40 UTC | Research Solutions, Inc. RSSS · Entity 6984 | GrantCommon Stock | 3,298 | $0.00 | $0.00 |
DisclosureSEC source: 0001104659-20-060997 · tm2019665d3_4.xml · nonDerivative · entry 1 URBAN ALAN LOUIS · CIK 0001534376 · CFO & Secretary 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 364,590 F1 · shares: Represents a grant of shares of restricted stock ("RSAs"). 1/3rd of the RSAs vest on May 12, 2021 and 1/12th of the RSAs vest on the last day of each quarter beginning June 30, 2021 until fully vested. Read SEC document |
| March 20, 2020 Filed Mar 25, 2020 01:28 UTC | Research Solutions, Inc. RSSS · Entity 6984 | Tax withholdingCommon Stock | 10,000 | $2.75 | $27,500.00 |
DisclosureSEC source: 0001104659-20-037926 · tm2013662d4_4.xml · nonDerivative · entry 1 URBAN ALAN LOUIS · CIK 0001534376 · CFO & Secretary 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 361,292 F1 · kind: The reporting person sold these shares to the registrant to cover taxes on vested restricted stock, as approved by the Compensation Committee of the Registrant's Board of Directors. Read SEC document |
| February 11, 2020 Filed Feb 14, 2020 20:47 UTC | Research Solutions, Inc. RSSS · Entity 6984 | GrantCommon Stock | 2,875 | $0.00 | $0.00 |
DisclosureSEC source: 0001104659-20-021603 · tm208202-3_4.xml · nonDerivative · entry 1 URBAN ALAN LOUIS · CIK 0001534376 · CFO & Secretary 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 371,292 F1 · shares: Represents a grant of shares of restricted stock ("RSAs"). 1/3rd of the RSAs vest on February 11, 2021 and 1/12th of the RSAs vest on the last day of each quarter beginning March 31, 2021 until fully vested. Read SEC document |
| January 01, 2020 Filed Jan 3, 2020 18:55 UTC | Research Solutions, Inc. RSSS · Entity 6984 | Exercise / conversionOptions to purchase Common Stock · Derivative | 100,000 | $0.00 Strike: $1.02 | $0.00 |
DisclosureSEC source: 0001104659-20-000725 · tm201205d1_4.xml · derivative · entry 7 URBAN ALAN LOUIS · CIK 0001534376 · CFO & Secretary 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 100,000 shares Expires 2020-07-27 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_date: The underlying shares vested and became exercisable ratably over three years on each quarterly anniversary of July 27, 2010, the date of grant. Read SEC document |
| January 01, 2020 Filed Jan 3, 2020 18:55 UTC | Research Solutions, Inc. RSSS · Entity 6984 | Exercise / conversionCommon Stock | 100,000 | $1.02 | $102,000.00 |
DisclosureSEC source: 0001104659-20-000725 · tm201205d1_4.xml · nonDerivative · entry 2 URBAN ALAN LOUIS · CIK 0001534376 · CFO & Secretary 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 368,417 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| January 01, 2020 Filed Jan 3, 2020 18:55 UTC | Research Solutions, Inc. RSSS · Entity 6984 | Tax withholdingCommon Stock | 28,334 | $3.60 | $102,002.40 |
DisclosureSEC source: 0001104659-20-000725 · tm201205d1_4.xml · nonDerivative · entry 1 URBAN ALAN LOUIS · CIK 0001534376 · CFO & Secretary 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 268,417 Read SEC document |
| December 20, 2019 Filed Dec 26, 2019 19:59 UTC | Research Solutions, Inc. RSSS · Entity 6984 | Disposition to issuerCommon Stock | 15,000 | $3.00 | $45,000.00 |
DisclosureSEC source: 0001104659-19-076082 · tm1927395-1_4.xml · nonDerivative · entry 1 URBAN ALAN LOUIS · CIK 0001534376 · CFO & Secretary 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 296,751 F1 · kind: The reporting person sold these shares to the registrant to cover taxes on vested restricted stock, as approved by the Compensation Committee of the Registrant's Board of Directors. Read SEC document |
| November 12, 2019 Filed Nov 15, 2019 02:15 UTC | Research Solutions, Inc. RSSS · Entity 6984 | GrantCommon Stock | 3,215 | $0.00 | $0.00 |
DisclosureSEC source: 0001104659-19-064452 · tm1923024-1_4.xml · nonDerivative · entry 1 URBAN ALAN LOUIS · CIK 0001534376 · CFO & Secretary 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 311,751 F1 · shares: Represents a grant of shares of restricted stock ("RSAs"). 1/3rd of the RSAs vest on November 12, 2020 and 1/12th of the RSAs vest on the last day of each quarter beginning December 31, 2020 until fully vested. Read SEC document |
| September 20, 2019 Filed Sep 24, 2019 20:43 UTC | Research Solutions, Inc. RSSS · Entity 6984 | Disposition to issuerCommon Stock | 7,750 | $2.50 | $19,375.00 |
DisclosureSEC source: 0001144204-19-045795 · tv530017_4.xml · nonDerivative · entry 1 URBAN ALAN LOUIS · CIK 0001534376 · CFO & Secretary 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 308,536 F1 · kind: The reporting person sold these shares to the registrant to cover taxes on vested restricted stock, as approved by the Compensation Committee of the Registrant's Board of Directors. Read SEC document |
| August 01, 2019 Filed Aug 5, 2019 10:17 UTC | Research Solutions, Inc. RSSS · Entity 6984 | GrantCommon Stock | 16,100 | $0.00 | $0.00 |
DisclosureSEC source: 0001144204-19-037531 · tv526716_4.xml · nonDerivative · entry 1 URBAN ALAN LOUIS · CIK 0001534376 · CFO & Secretary 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 316,286 F1 · shares: Represents a grant of shares of restricted stock ("RSAs"). 1/3rd of the RSAs vest on August 1, 2020 and 1/12th of the RSAs vest on the last day of each quarter beginning September 30, 2020 until fully vested. Read SEC document |
| June 20, 2019 Filed Jun 24, 2019 23:54 UTC | Research Solutions, Inc. RSSS · Entity 6984 | Disposition to issuerCommon Stock | 4,100 | $2.30 | $9,430.00 |
DisclosureSEC source: 0001144204-19-032113 · tv524193_4.xml · nonDerivative · entry 1 URBAN ALAN LOUIS · CIK 0001534376 · CFO & Secretary 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 300,186 F1 · kind: The reporting person sold these shares to the registrant to cover taxes on vested restricted stock, as approved by the Compensation Committee of the Registrant's Board of Directors. Read SEC document |
| May 17, 2019 Filed May 20, 2019 20:46 UTC | Research Solutions, Inc. RSSS · Entity 6984 | GrantCommon Stock | 1,813 | $0.00 | $0.00 |
DisclosureSEC source: 0001144204-19-027323 · tv522098_4.xml · nonDerivative · entry 1 URBAN ALAN LOUIS · CIK 0001534376 · CFO & Secretary 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 304,286 F1 · shares: Represents a grant of shares of restricted stock ("RSAs"). 1/3rd of the RSAs vest on May 17, 2020 and 1/12th of the RSAs vest on the last day of each quarter beginning June 30, 2020 until fully vested. Read SEC document |
| March 20, 2019 Filed Mar 22, 2019 20:17 UTC | Research Solutions, Inc. RSSS · Entity 6984 | Disposition to issuerCommon Stock | 5,600 | $2.24 | $12,544.00 |
DisclosureSEC source: 0001144204-19-015584 · tv516960_4.xml · nonDerivative · entry 1 URBAN ALAN LOUIS · CIK 0001534376 · CFO & Secretary 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 302,473 F1 · kind: The reporting person sold these shares to the registrant to cover taxes on vested restricted stock, as approved by the Compensation Committee of the Registrant's Board of Directors. Read SEC document |
| February 07, 2019 Filed Feb 8, 2019 17:03 UTC | Research Solutions, Inc. RSSS · Entity 6984 | GrantCommon Stock | 2,794 | $0.00 | $0.00 |
DisclosureSEC source: 0001144204-19-005750 · tv512810_4.xml · nonDerivative · entry 1 URBAN ALAN LOUIS · CIK 0001534376 · CFO & Secretary 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 308,073 F1 · shares: Represents a grant of shares of restricted stock ("RSAs"). 1/3rd of the RSAs vest on February 7, 2020 and 1/12th of the RSAs vest on the last day of each quarter beginning March 31, 2020 until fully vested. Read SEC document |
| December 20, 2018 Filed Dec 21, 2018 23:35 UTC | Research Solutions, Inc. RSSS · Entity 6984 | Disposition to issuerCommon Stock | 4,100 | $2.41 | $9,881.00 |
DisclosureSEC source: 0001144204-18-066104 · tv509765_4.xml · nonDerivative · entry 1 URBAN ALAN LOUIS · CIK 0001534376 · CFO & Secretary 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 305,279 F1 · kind: The reporting person sold these shares to the registrant to cover taxes on vested restricted stock, as approved by the Compensation Committee of the Registrant's Board of Directors. Read SEC document |
| November 13, 2018 Filed Nov 16, 2018 01:53 UTC | Research Solutions, Inc. RSSS · Entity 6984 | GrantCommon Stock | 3,470 | $0.00 | $0.00 |
DisclosureSEC source: 0001144204-18-060352 · tv507463_form4.xml · nonDerivative · entry 1 URBAN ALAN LOUIS · CIK 0001534376 · CFO & Secretary 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 309,379 F1 · shares: Represents a grant of shares of restricted stock ("RSAs"). 1/3rd of the RSAs vest on November 13, 2019 and 1/12th of the RSAs vest on the last day of each quarter beginning December 31, 2019 until fully vested. Read SEC document |
| September 20, 2018 Filed Sep 26, 2018 00:39 UTC | Research Solutions, Inc. RSSS · Entity 6984 | Disposition to issuerCommon Stock | 8,100 | $2.20 | $17,820.00 |
DisclosureSEC source: 0001144204-18-050796 · tv503521_4.xml · nonDerivative · entry 1 URBAN ALAN LOUIS · CIK 0001534376 · CFO & Secretary 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 305,909 F1 · kind: The reporting person sold these shares to the registrant to cover taxes on vested restricted stock, as approved by the Compensation Committee of the Registrant's Board of Directors. Read SEC document |
| August 09, 2018 Filed Aug 13, 2018 16:52 UTC | Research Solutions, Inc. RSSS · Entity 6984 | GrantCommon Stock | 29,929 | $0.00 | $0.00 |
DisclosureSEC source: 0001144204-18-043880 · tv500742_form4.xml · nonDerivative · entry 1 URBAN ALAN LOUIS · CIK 0001534376 · CFO & Secretary 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 314,009 F1 · shares: Represents a grant of shares of restricted stock ("RSAs"). 1/3rd of the RSAs vest on August 9, 2019 and 1/12th of the RSAs vest on the last day of each quarter beginning September 30, 2019 until fully vested. Read SEC document |
| June 20, 2018 Filed Jun 22, 2018 20:43 UTC | Research Solutions, Inc. RSSS · Entity 6984 | Disposition to issuerCommon Stock | 4,200 | $1.73 | $7,266.00 |
DisclosureSEC source: 0001144204-18-035408 · tv497072_4.xml · nonDerivative · entry 1 URBAN ALAN LOUIS · CIK 0001534376 · CFO & Secretary 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 284,080 F1 · kind: The reporting person sold these shares to the registrant to cover taxes on vested restricted stock, as approved by the Compensation Committee of the Registrant's Board of Directors. Read SEC document |
| May 10, 2018 Filed May 11, 2018 21:59 UTC | Research Solutions, Inc. RSSS · Entity 6984 | GrantCommon Stock | 8,395 | $0.00 | $0.00 |
DisclosureSEC source: 0001144204-18-027727 · tv493905_form4.xml · nonDerivative · entry 1 URBAN ALAN LOUIS · CIK 0001534376 · CFO & Secretary 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 288,280 F1 · shares: Represents a grant of shares of restricted stock ("RSAs"). 1/3rd of the RSAs vest on May 10, 2019 and 1/12th of the RSAs vest on the last day of each quarter beginning June 30, 2019 until fully vested. Read SEC document |
| March 20, 2018 Filed Mar 23, 2018 01:30 UTC | Research Solutions, Inc. RSSS · Entity 6984 | Disposition to issuerCommon Stock | 5,850 | $1.29 | $7,546.50 |
DisclosureSEC source: 0001144204-18-016512 · tv489352_4.xml · nonDerivative · entry 1 URBAN ALAN LOUIS · CIK 0001534376 · CFO & Secretary 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 279,885 F1 · kind: The reporting person sold these shares to the registrant to cover taxes on vested restricted stock, as approved by the Compensation Committee of the Registrant's Board of Directors. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.